Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GF-001001-00 in Secondarily-Infected Traumatic Lesions
NCT01005771Phase 2Completed
- Sponsor
- Ferrer
- Start
- Sep 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ozenoxacin in post-traumatic wound infection, sponsored by Ferrer. Started Sep 2009; status: completed.
02
Drugs
ozenoxacin
03
Conditions
post-traumatic wound infection
Beyond the preview
Go deeper on NCT01005771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01005771.